Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Eeva, Rahko"'
Autor:
Raimo Goyarrola, Jari Lipsanen, Suvi-Maria Saarelainen, Raili Suviranta, Eeva Rahko, Annamarja Lamminmäki, Tuula Klaavuniemi, Satu Ahtiluoto, Antti Ohvanainen, Pekka Metso, Reino Pöyhiä
Publikováno v:
BMC Palliative Care, Vol 22, Iss 1, Pp 1-13 (2023)
Abstract Background The European Organisation for Research and Treatment of Cancer (EORTC) has developed the Spiritual Well-being Questionnaire (EORTC QLQ-SWB32), a measure of spiritual well-being validated with people receiving palliative care for c
Externí odkaz:
https://doaj.org/article/6ddf62814766429398979974720c1e1d
Autor:
Katri S. Selander, Kevin W. Harris, Katri S. Vuopala, Arja Jukkola-Vuorinen, Eeva Rahko, Sonja Brooks, David Graves, Savita Wakchoure, Li Li, Melinda A. Merrell, Joanna M. Ilvesaro
Toll-like receptor 9 (TLR9) belongs to the innate immune system and recognizes microbial and vertebrate DNA. We showed previously that treatment with the TLR9-agonistic ODN M362 (a CpG sequence containing oligonucleotide) induces matrix metalloprotei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bae934a7bac138c87ef3979caed3daa8
https://doi.org/10.1158/1541-7786.c.6541396.v1
https://doi.org/10.1158/1541-7786.c.6541396.v1
Autor:
Katri S. Selander, Kevin W. Harris, Katri S. Vuopala, Arja Jukkola-Vuorinen, Eeva Rahko, Sonja Brooks, David Graves, Savita Wakchoure, Li Li, Melinda A. Merrell, Joanna M. Ilvesaro
Supplementary Figure S1 from Toll-Like Receptor 9 Mediates CpG Oligonucleotide–Induced Cellular Invasion
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8930ab4a5095213377bb3f751bdc68c7
https://doi.org/10.1158/1541-7786.22516525.v1
https://doi.org/10.1158/1541-7786.22516525.v1
Publikováno v:
Journal of Palliative Care. :082585972311718
Objective: To study whether E-learning methods are feasible in the post-graduate education of palliative medicine. Methods: A mixed-methods study. Evaluations from pilot course attendees were analyzed numerically and answers to open-ended questions a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::714883d891fa9ff0d724505e5dc9392a
https://doi.org/10.1177/08258597231171823
https://doi.org/10.1177/08258597231171823
Autor:
Raimo Goyarrola, Jari Lipsanen, Suvi-Maria Saarelainen, Raili Suviranta, Eeva Rahko, Annamarja Lamminmäki, Tuula Klaavuniemi, Satu Ahtiluoto, Antti Ohvanainen, Pekka Metso, Reino Pöyhiä
Background The European Organisation for Research and Treatment of Cancer (EORTC) has developed the Spiritual Well-being Questionnaire (EORTC QLQ-SWB32), a measure of spiritual well-being validated with people receiving palliative care for cancer, al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67926f7cc3fd7322f346b9b8d784f1f1
https://doi.org/10.21203/rs.3.rs-1740732/v1
https://doi.org/10.21203/rs.3.rs-1740732/v1
Autor:
Juho T. Lehto, Tiina Saarto, Eeva Rahko, Lotta Grönholm, Olli Haltia, Riikka-Leena Leskelä, Kristiina Tyynelä-Korhonen, Outi Hirvonen, Antti Rissanen
Publikováno v:
Acta Oncologica. 58:1699-1705
Background: To avoid aggressive treatments at the end-of-life and to provide palliative care (PC), physicians need to terminate futile anti-cancer treatments and define the palliative goal of the treatment in time. This single center study assesses t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::117af25b964e720048d5480a9021b9ac
https://doi.org/10.1080/0284186x.2019.1659512
https://doi.org/10.1080/0284186x.2019.1659512
Publikováno v:
BMC Medical Education
BMC Medical Education, Vol 21, Iss 1, Pp 1-12 (2021)
BMC Medical Education, Vol 21, Iss 1, Pp 1-12 (2021)
Background Globally, the need for palliative care will increase as a result of the ageing of populations and the rising burden of cancer, non-communicable diseases as well as some communicable diseases. Physicians and registered nurses working in pal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34889599d77a731edd230c59b28bbc45
http://urn.fi/urn:nbn:fi-fe2022020717865
http://urn.fi/urn:nbn:fi-fe2022020717865
Autor:
Kristiina Tyynelä-Korhonen, Lotta Grönholm, Olli Haltia, Riikka-Leena Leskelä, Outi Hirvonen, Juho T. Lehto, Samuli Voltti, Tiina Saarto, Eeva Rahko
Publikováno v:
BMC Palliative Care
BMC Palliative Care, Vol 19, Iss 1, Pp 1-9 (2020)
BMC Palliative Care, Vol 19, Iss 1, Pp 1-9 (2020)
Background In order to avoid unnecessary use of hospital services at the end-of-life, palliative care should be initiated early enough in order to have sufficient time to initiate and carry out good quality advance care planning (ACP). This single ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a6a0bdca51947a5adb841d363ca08e4
http://europepmc.org/articles/PMC7093948
http://europepmc.org/articles/PMC7093948
Autor:
Sonja C. Brooks, David E. Graves, Arja Jukkola-Vuorinen, Savita Wakchoure, Eeva Rahko, Li Li, Katri S. Selander, Kevin W. Harris, Joanna M. Ilvesaro, Katri S. Vuopala, Melinda A. Merrell
Publikováno v:
Molecular Cancer Research. 6:1534-1543
Toll-like receptor 9 (TLR9) belongs to the innate immune system and recognizes microbial and vertebrate DNA. We showed previously that treatment with the TLR9-agonistic ODN M362 (a CpG sequence containing oligonucleotide) induces matrix metalloprotei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54f3607411ab1dc4ac03b1691a009160
https://doi.org/10.1158/1541-7786.mcr-07-2005
https://doi.org/10.1158/1541-7786.mcr-07-2005
Autor:
Anne Talvensaari-Mattila, Risto Bloigu, Arja Jukkola, Ylermi Soini, Eeva Rahko, Guillermo Blanco
Publikováno v:
The Breast. 15:69-75
The prognostic and predictive relevance of p53 immunoreactivity is used here as a tentative approach for defining more accurately the benefit of adjuvant hormonal therapy in postmenopausal node-positive breast cancer patients. Ninety-seven postmenopa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05f49a16f915881967db708768a89ac9
https://doi.org/10.1016/j.breast.2005.04.004
https://doi.org/10.1016/j.breast.2005.04.004